These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11095158)

  • 21. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology and prevention of diabetic nephropathy.
    Brancati FL; Cusumano AM
    Curr Opin Nephrol Hypertens; 1995 May; 4(3):223-9. PubMed ID: 7648216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies.
    Zanella MT; Ribeiro AB
    Clin Ther; 2002 Jul; 24(7):1019-34. PubMed ID: 12182249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters.
    Al-Rubeaan K; Siddiqui K; Alghonaim M; Youssef AM; AlNaqeb D
    Ann Saudi Med; 2018; 38(1):46-56. PubMed ID: 29295969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is antihypertensive treatment the same for NIDDM and IDDM patients?
    Parving HH
    Diabetes Res Clin Pract; 1998 Apr; 39 Suppl():S43-7. PubMed ID: 9649959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of ALOX12 gene polymorphism with all-cause and cardiovascular mortality in diabetic nephropathy.
    Roumeliotis AK; Roumeliotis SK; Panagoutsos SA; Tsetsos F; Georgitsi M; Manolopoulos V; Paschou P; Passadakis PS
    Int Urol Nephrol; 2018 Feb; 50(2):321-329. PubMed ID: 29196930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive treatment and multifactorial approach for renal protection in diabetes.
    Fioretto P; Solini A
    J Am Soc Nephrol; 2005 Mar; 16 Suppl 1():S18-21. PubMed ID: 15938027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nephropathy in type 2 diabetes.
    Ritz E
    J Intern Med; 1999 Feb; 245(2):111-26. PubMed ID: 10081514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment.
    Ayodele OE; Alebiosu CO; Salako BL
    J Natl Med Assoc; 2004 Nov; 96(11):1445-54. PubMed ID: 15586648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microalbuminuria in type 1 and type 2 diabetes mellitus: evidence with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers for treating early and preventing clinical nephropathy.
    Parving HH; Hovind P
    Curr Hypertens Rep; 2002 Oct; 4(5):387-93. PubMed ID: 12217258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
    Thomas MC; Atkins RC
    Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kidney involvement and disease in patients with diabetes.
    Chiarelli F; Trotta D; Verrotti A; Mohn A
    Panminerva Med; 2003 Mar; 45(1):23-41. PubMed ID: 12682618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical manifestation and natural history of diabetic nephropathy.
    Ritz E; Zeng XX; Rychlík I
    Contrib Nephrol; 2011; 170():19-27. PubMed ID: 21659754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention and slowing down the progression of the diabetic nephropathy through antihypertensive therapy.
    Bretzel RG
    J Diabetes Complications; 1997; 11(2):112-22. PubMed ID: 9101397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.
    Bakris GL; Williams M; Dworkin L; Elliott WJ; Epstein M; Toto R; Tuttle K; Douglas J; Hsueh W; Sowers J
    Am J Kidney Dis; 2000 Sep; 36(3):646-61. PubMed ID: 10977801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodialysis in diabetic patients.
    Akmal M
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S195-9. PubMed ID: 11576954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Guidelines for diagnosis and therapy of diabetic nephropathy].
    De Ferrari G;
    G Ital Nefrol; 2003; 20 Suppl 24():S96-108. PubMed ID: 14666506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of nephropathy in patients with type 2 diabetes.
    Critchley JA; Zhao HL; Tomlinson B; Leung W; Thomas GN; Chan JC; Cockram CS
    Chin Med J (Engl); 2002 Jan; 115(1):129-35. PubMed ID: 11930647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.